CVS Health
CVS
1,574 hedge funds and large institutions have $84B invested in CVS Health in 2016 Q2 according to their latest regulatory filings, with 99 funds opening new positions, 674 increasing their positions, 653 reducing their positions, and 72 closing their positions.
38% more first-time investments, than exits
New positions opened: 99 | Existing positions closed: 72
23% more call options, than puts
Call options by funds: $562M | Put options by funds: $456M
3% more repeat investments, than reductions
Existing positions increased: 674 | Existing positions reduced: 653
1% more funds holding
Funds holding: 1,563 → 1,574 (+11)
0.31% less ownership
Funds ownership: 81.97% → 81.66% (-0.31%)
10% less capital invested
Capital invested by funds: $93.6B → $84B (-$9.68B)
26% less funds holding in top 10
Funds holding in top 10: 239 → 176 (-63)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$537M |
| 2 |
Nordea Investment Management
Stockholm,
Sweden
|
+$441M |
| 3 |
Renaissance Technologies
New York
|
+$363M |
| 4 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
+$139M |
| 5 |
SI
Sentry Investments
Toronto,
Ontario, Canada
|
+$135M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$712M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$631M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$474M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$459M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$259M |
CVS Hedge Fund Activity: Q2 2016 in Review
1,574 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q2 2016, worth a combined $84B — down 10% from $93.6B a quarter earlier.
Buyers outnumbered sellers: 99 funds opened new CVS positions and 72 closed out — a net gain of 27 holders — while 674 added to existing stakes and 653 trimmed.
The largest buyer was D.E. Shaw & Co, adding an estimated $537M. The largest seller was T. Rowe Price Associates, cutting an estimated $712M.
- 1,574 institutional investors held CVS Health (CVS) as of Q2 2016, up from 1,563 in Q1 2016.
- Funds reported $84B of CVS Health stock for Q2 2016, down 10% quarter-over-quarter.
- 99 funds opened new CVS Health positions in Q2 2016 and 72 closed out, a net change of +27 holders.
- The largest CVS Health buyer in Q2 2016 was D.E. Shaw & Co, an estimated $537M added.
- The largest CVS Health seller in Q2 2016 was T. Rowe Price Associates, an estimated $712M sold.
Based on aggregated 13F filings for Q2 2016.